Form 4: BioLife Solutions CMO Berard Boosts Stake

BioLife Solutions Chief Marketing Officer Todd Berard increased his direct beneficial ownership of common stock through restricted stock grants, partially offset by shares withheld for taxes.

Summary

• Todd Berard, Chief Marketing Officer of BioLife Solutions Inc. (BLFS), reported transactions on February 24, 2026.
• Acquired 20,096 shares of common stock as restricted stock, part of 2026 compensation, vesting 25% on the first anniversary of the grant date and quarterly thereafter.
• Acquired an additional 22,479 shares of common stock as restricted stock, which vested based on the registrant's total shareholder return compared to peers from January 1, 2024, through December 31, 2025.
• Disposed of 8,846 shares of common stock at a price of $22.65 per share to cover tax withholding obligations related to the vesting of a market-based restricted stock award.
• Following these transactions, Berard directly beneficially owns 166,293 shares of common stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively as it indicates increased insider ownership and successful achievement of performance targets for a significant portion of the grants, aligning management's interests with long-term shareholder value.

Positives

• Chief Marketing Officer Todd Berard increased his direct beneficial ownership of BioLife Solutions common stock by a net of 33,729 shares (20,096 + 22,479 8,846).
• A significant portion of the acquired shares (22,479) vested based on the company's total shareholder return performance against its peers, indicating achievement of performance targets.
• The grant of 20,096 restricted shares as part of 2026 compensation aligns management's interests with long-term shareholder value.

Negatives

• 8,846 shares were disposed of at $22.65 per share to cover tax withholding obligations, representing a reduction in direct ownership.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the vesting schedule for the restricted stock grants.

Industry Context

StockSavvy.ai notes that insider transactions, particularly grants and subsequent vesting, are common forms of executive compensation designed to align management incentives with shareholder interests. The performance-based vesting component is a strong indicator of a compensation structure tied to company success relative to its peers.

Corporate Governance

Related Party Transactions

• The reported transactions involve the acquisition and disposition of company stock by a Chief Marketing Officer, which are inherently related-party transactions.

Stakeholder Impact

• Shareholders: Increased direct beneficial ownership by a key executive can signal confidence in the company's future and better align management's interests with shareholder returns.
• Employees: The use of performance-based restricted stock awards can motivate executives to achieve strategic goals.

Next Steps

• The remaining 75% of the 20,096 restricted shares will vest in 12 equal quarterly installments following the first anniversary of the grant date (February 24, 2027).

Key Dates

Keywords

BioLife Solutions, BLFS, Todd Berard, Insider Transaction, Form 4, Restricted Stock, Executive Compensation, Stock Grant, Beneficial Ownership